Abiopharma

Prior Stephen David 🔴 sold 6.5K shares of AN2 Therapeutics, Inc. (ANTX) at $1.01 Transaction Date: Jan 05, 2026 | Filing ID: 006770

Ward Shane 🔴 sold 241.8K shares (5 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($8.9M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Davarpanah Nicole Negar 🔴 sold 149.5K shares (5 derivative) of Cidara Therapeutics, Inc. (CDTX) at $221.50 ($4.8M) Transaction Date: Jan 07, 2026 | Filing ID: 000002

Chanda Sanjay 🔴 sold 9.3K shares of AN2 Therapeutics, Inc. (ANTX) at $1.01 Transaction Date: Jan 05, 2026 | Filing ID: 006765

Director Stein Jeffrey 🟡 adjusted position in 1.9K shares of Cidara Therapeutics, Inc. (CDTX) at $155.00 Transaction Date: May 23, 2016 | Filing ID: 000004

Eizen Joshua M 🔴 sold 24.9K shares of AN2 Therapeutics, Inc. (ANTX) at $1.01 Transaction Date: Jan 05, 2026 | Filing ID: 006763

NASDAQ traded attribute type Security_Name was changed. Previous value: Cidara Therapeutics, Inc. - Common Stock. New value: Cidara Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: FibroGen, Inc - Common Stock. New value: FibroGen, Inc - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Cidara Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Cidara Therapeutics, Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Salarius Pharmaceuticals, Inc. - Common Stock. New value: Salarius Pharmaceuticals, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Salarius Pharmaceuticals, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Salarius Pharmaceuticals, Inc. - Common Stock.